These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4004487)

  • 1. [Effects of weakly androgenic anabolic steroids on growth in Turner's syndrome].
    Muritano MR; Job JC
    Arch Fr Pediatr; 1985 Apr; 42(4):265-71. PubMed ID: 4004487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth hormone for Turner's syndrome].
    Fishman A; Hochberg Z
    Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of pituitary dwarfism with synthetic anabolic drugs].
    Canlorbe P; Borniche P; Job JC; Bader JC
    Ann Pediatr (Paris); 1969 Oct; 16(10):590-602. PubMed ID: 4311469
    [No Abstract]   [Full Text] [Related]  

  • 4. [The current treatment concept of Turner syndrome].
    Blümel P; Stögmann W
    Padiatr Padol; 1989; 24(1):81-9. PubMed ID: 2654820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM; Rekers-Mombarg LT; Cutler GB; Crowe B; Beck TJ; Roberts K; Gill A; Chaussain JL; Frisch H; Yturriaga R; Attanasio AF
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stature after 18 months of treatment with synthetic growth hormone in 12 patients with Turner's syndrome].
    Leheup B; Pierson M
    J Genet Hum; 1989 Jan; 37(1):55-60. PubMed ID: 2715783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biosynthetic growth hormone in the treatment of low stature in Turner syndrome].
    Mendoza-Morfín F; Montero-González P; Cárdenas-Tirado H; Bravo-Ríos LE
    Rev Invest Clin; 1995; 47(5):371-6. PubMed ID: 8584807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Height in Turner's syndrome: correlation with parents' height].
    Salerno MC; Job JC
    Arch Fr Pediatr; 1987 Dec; 44(10):863-5. PubMed ID: 3446059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose testosterone effect on somatic growth.
    Rosenfield RL
    Pediatrics; 1986 Jun; 77(6):853-7. PubMed ID: 3714378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
    Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H
    Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous growth of girls with Turner's syndrome until 6 years of age].
    Wiśniewski A; Milde K; Stupnicki R
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):7-11. PubMed ID: 16704855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 2 anabolic steroids on "essential" delayed growth].
    Canlorbe P; Borniche P; Bader JC
    Ann Pediatr (Paris); 1969 Oct; 16(10):582-9. PubMed ID: 4311468
    [No Abstract]   [Full Text] [Related]  

  • 13. Final height in estrogen-treated patients with Turner syndrome.
    Demetriou E; Emans SJ; Crigler JF
    Obstet Gynecol; 1984 Oct; 64(4):459-64. PubMed ID: 6091005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
    Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
    Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
    Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Turner's syndrome: growth, endocrinological study and other aspects].
    Vázquez Alvarez J; Fernández Toral J; Martín Muñiz C; Salmerón Alvarez M; Roca Martínez A; de la Fuente Ciruelas P
    An Esp Pediatr; 1997 Apr; 46(4):357-61. PubMed ID: 9214227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of growth retardation with androgens in Turner's syndrome].
    Sorensen K; Nielsen J
    Ugeskr Laeger; 1977 Oct; 139(43):2559-61. PubMed ID: 337609
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
    Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
    Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.